Join the 5th edition of this international brokerage event dedicated to Horizon Europe Cluster 1 Health and the EU Cancer Mission. The event is designed for researchers, healthcare professionals, innovators, companies, policymakers and other stakeholders interested in building consortia for the upcoming 2027 Horizon Europe calls.
Participants will gain insights into the 2027 funding opportunities from representatives of the European Commission and leading European experts, while networking with potential partners from across Europe. The programme includes pitching sessions, matchmaking opportunities and discussions to help participants develop competitive project proposals.
Pitching sessions will focus on three thematic areas:
- Healthcare Innovation
- Clinical Trials
- Digital Health & Artificial Intelligence
Event details:
📅 Date: September 28, 2026, 12:30- 19:00 (CEST)
📍Venue :Comet Meetings (Pl. Stéphanie 20, 1050 Bruxelles)
📃 Preliminary agenda is added at the bottom of the page
The registration of the event will be opened in due time.
Horizon Europe calls dedicated for this event
Healthcare innovations:
- Leveraging functional genomics to reveal novel targets for cancer treatment HORIZON-MISS-2027-02-CANCER-01
- Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications HORIZON-HLTH-2027-01-CARE-02
- Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research HORIZON-MISS-2027-02-CANCER-04
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines HORIZON-MISS-2027-02-CANCER-05
Clinical trials:
- Prevention and management of chronic non-communicable diseases in children and young people (GACD) HORIZON-HLTH-2027-01-DISEASE-10
- Clinical trials for advancing innovative interventions for neurodegenerative diseases HORIZON-HLTH-2027-02-DISEASE-14-two-stage
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes HORIZON-MISS-2027-02-CANCER-03
- Innovative healthcare interventions for non-communicable diseases HORIZON-HLTH-2027-02-DISEASE-01-two-stage
Digital health and AI:
- Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis HORIZON-HLTH-2027-03-TOOL-04
- Towards Artificial General Intelligence (AGI) for healthcare HORIZON-HLTH-2027-03-TOOL-08
- Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases HORIZON-HLTH-2027-02-TOOL-01-two-stage
The event is co-organised by the Research Council of Lithuania National Contact Points (NCPs) in collaboration with the Lithuanian Research Development and Innovation Liaison Office in Brussels (LINO), the NCBR Office in Brussels, and partner NCPs from Poland, France and Belgium.
